Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.790
-0.210 (-4.20%)
Apr 29, 2026, 10:30 AM EDT - Market open
Opus Genetics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 45.09 | 30.32 | 50.5 | 42.63 | 24.53 | Upgrade
|
| Short-Term Investments | - | 0 | 0.02 | 0.05 | 0.22 | Upgrade
|
| Cash & Short-Term Investments | 45.09 | 30.32 | 50.52 | 42.68 | 24.75 | Upgrade
|
| Cash Growth | 48.70% | -39.97% | 18.35% | 72.44% | 50.94% | Upgrade
|
| Accounts Receivable | 3.17 | 5.77 | 2.33 | 4.85 | - | Upgrade
|
| Receivables | 3.17 | 5.77 | 2.33 | 4.85 | - | Upgrade
|
| Prepaid Expenses | 1.79 | 0.52 | 1.1 | 1.37 | 1.24 | Upgrade
|
| Other Current Assets | - | - | - | 0.08 | 0.07 | Upgrade
|
| Total Current Assets | 50.04 | 36.61 | 53.95 | 48.99 | 26.07 | Upgrade
|
| Property, Plant & Equipment | 0.2 | 0.25 | - | 0.01 | 0.01 | Upgrade
|
| Total Assets | 50.24 | 36.86 | 53.95 | 48.99 | 26.08 | Upgrade
|
| Accounts Payable | 3.29 | 3.15 | 2.15 | 1.07 | 1.58 | Upgrade
|
| Accrued Expenses | 4.47 | 7.54 | 1.82 | 1.37 | 1.73 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.54 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.32 | - | Upgrade
|
| Other Current Liabilities | 0.02 | 0.61 | 0.07 | - | - | Upgrade
|
| Total Current Liabilities | 7.78 | 11.3 | 4.04 | 2.75 | 3.86 | Upgrade
|
| Long-Term Debt | 1.13 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 25.99 | - | - | - | - | Upgrade
|
| Total Liabilities | 34.9 | 11.3 | 4.04 | 2.75 | 3.86 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 203.93 | 145.72 | 131.37 | 117.72 | 111.59 | Upgrade
|
| Retained Earnings | -188.59 | -139 | -81.47 | -71.48 | -89.37 | Upgrade
|
| Total Common Equity | 15.35 | 6.72 | 49.91 | 46.24 | 22.22 | Upgrade
|
| Shareholders' Equity | 15.35 | 25.57 | 49.91 | 46.24 | 22.22 | Upgrade
|
| Total Liabilities & Equity | 50.24 | 36.86 | 53.95 | 48.99 | 26.08 | Upgrade
|
| Total Debt | 1.13 | - | - | - | 0.54 | Upgrade
|
| Net Cash (Debt) | 43.96 | 30.32 | 50.52 | 42.68 | 24.22 | Upgrade
|
| Net Cash Growth | 44.98% | -39.97% | 18.35% | 76.27% | 47.66% | Upgrade
|
| Net Cash Per Share | 0.71 | 1.14 | 2.34 | 2.07 | 1.63 | Upgrade
|
| Filing Date Shares Outstanding | 71.15 | 45.48 | 24.81 | 20.95 | 18.99 | Upgrade
|
| Total Common Shares Outstanding | 69.89 | 31.57 | 23.98 | 20.86 | 18.85 | Upgrade
|
| Working Capital | 42.26 | 25.32 | 49.91 | 46.23 | 22.21 | Upgrade
|
| Book Value Per Share | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 | Upgrade
|
| Tangible Book Value | 15.35 | 6.72 | 49.91 | 46.24 | 22.22 | Upgrade
|
| Tangible Book Value Per Share | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 | Upgrade
|
| Machinery | - | - | - | 0.03 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.